Dan G. Duda, DMD, Ph.D., of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at ...

Tina Willits, now 53, thought she had just two years to live. Today, she is cancer-free — and she wants the world to know about the treatment that saved her.

As the founder and CEO of Immunocine Cancer Center, based in Cancún, Mexico, he has transformed his vision into reality with ...

For decades, the go-to treatments for cancer have been chemotherapy, radiation and surgery — but some experts are calling ...

India is revolutionising cancer care with advanced diagnostics, genetic testing, and innovative treatments like immunotherapy ...

Dan G. Duda, DMD, PhD, of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at Massachusetts General Hospital, is the corresponding author of a paper published in ...

CAN-2409 resulted in disease-free survival improvements for patients with high-risk, localized prostate cancer.

Dan G. Duda, DMD, PhD, of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at Massachusetts General Hospital ...

The immunotherapy, CAN-2409, in combination with radiation therapy, helped 75.2% patients live without any sign of the cancer after 54 months of treatment, the company said on Wednesday.

Last year, 6-year-old Quinn D’Amico-Valliere faced a daunting diagnosis: a high-risk neuroblastoma, a rare and aggressive ...

FDA approved for the treatment of patients with metastatic or locally advanced cutaneous squamous cell carcinoma that is not ...